{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CYP3A4", "HPLC-DAD", "flavonoids", "testosterone"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30301254", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "07"}], "Language": ["eng"], "ELocationID": ["2553", "10.3390/molecules23102553"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "23", "Issue": "10", "PubDate": {"Year": "2018", "Month": "Oct", "Day": "07"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "The Inhibitory Effect of Flavonoid Aglycones on the Metabolic Activity of CYP3A4 Enzyme.", "Abstract": {"AbstractText": ["Flavonoids are natural compounds that have been extensively studied due to their positive effects on human health. There are over 4000 flavonoids found in higher plants and their beneficial effects have been shown in vitro as well as in vivo. However, data on their pharmacokinetics and influence on metabolic enzymes is scarce. The aim of this study was to focus on possible interactions between the 30 most commonly encountered flavonoid aglycones on the metabolic activity of CYP3A4 enzyme. 6\u03b2-hydroxylation of testosterone was used as marker reaction of CYP3A4 activity. Generated product was determined by HPLC coupled with diode array detector. Metabolism and time dependence, as well as direct inhibition, were tested to determine if inhibition was reversible and/or irreversible. Out of the 30 flavonoids tested, 7 significantly inhibited CYP3A4, most prominent being acacetin that inhibited 95% of enzyme activity at 1 \u00b5M concentration. Apigenin showed reversible inhibition, acacetin, and chrysin showed combined irreversible and reversible inhibition while chrysin dimethylether, isorhamnetin, pinocembrin, and tangeretin showed pure irreversible inhibition. These results alert on possible flavonoid\u207bdrug interactions on the level of CYP3A4."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "PDS Biology, Faculty of Science, University of Zagreb, Rooseveltov trg 6, 10000 Zagreb, Croatia. darija.saric.mustapic@halmed.hr."}, {"Identifier": [], "Affiliation": "Agency for Medicinal Products and Medical Devices, Ksaverska cesta 4, 10000 Zagreb, Croatia. darija.saric.mustapic@halmed.hr."}], "LastName": "\u0160ari\u0107 Mustapi\u0107", "ForeName": "Darija", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Clinical Laboratory Diagnostics, Osijek University Hospital Center, Josipa Huttlera 4, 31000 Osijek, Croatia. debeljak.zeljko@kbo.hr."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, University of Osijek, Cara Hadrijana 10/E, 31000 Osijek, Croatia. debeljak.zeljko@kbo.hr."}], "LastName": "Debeljak", "ForeName": "\u017deljko", "Initials": "\u017d"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Botany, Faculty of Pharmacy and Biochemistry, University of Zagreb, Schrottova 39, 10000 Zagreb, Croatia. zmales@pharma.hr."}], "LastName": "Male\u0161", "ForeName": "\u017deljan", "Initials": "\u017d"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kova\u010di\u0107a 1, 10000 Zagreb, Croatia. mbojic@pharma.hr."}], "LastName": "Boji\u0107", "ForeName": "Mirza", "Initials": "M"}], "GrantList": [{"GrantID": "UIP-2014-09-5704", "Agency": "Hrvatska Zaklada za Znanost", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytochrome P-450 CYP3A Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "07X3IB4R4Z", "NameOfSubstance": "3-methylquercetin"}, {"RegistryNumber": "3CN01F5ZJ5", "NameOfSubstance": "chrysin"}, {"RegistryNumber": "3XMK78S47O", "NameOfSubstance": "Testosterone"}, {"RegistryNumber": "7V515PI7F6", "NameOfSubstance": "Apigenin"}, {"RegistryNumber": "8T7C8CH791", "NameOfSubstance": "pinocembrin"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP3A"}, {"RegistryNumber": "EC 1.14.14.55", "NameOfSubstance": "CYP3A4 protein, human"}, {"RegistryNumber": "I4TLA1DLX6", "NameOfSubstance": "tangeretin"}, {"RegistryNumber": "KWI7J0A2CC", "NameOfSubstance": "acacetin"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Apigenin"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["chemistry", "drug effects", "metabolism"], "DescriptorName": "Cytochrome P-450 CYP3A"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cytochrome P-450 CYP3A Inhibitors"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavanones"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavones"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": ["chemistry"], "DescriptorName": "Testosterone"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Medi\u0107-\u0160ari\u0107 M., Jasprica I., Smol\u010di\u0107-Bubalo A., Mornar A. Optimization of chromatographic conditions in thin layer chromatography of flavonoids and phenolic acids. Croat. Chem. Acta. 2004;77:361\u2013366."}, {"Citation": "Benavente-Garcia O., Castillo J. Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008;56:6185\u20136205. doi: 10.1021/jf8006568.", "ArticleIdList": ["10.1021/jf8006568", "18593176"]}, {"Citation": "Boji\u0107 M., Debeljak \u017d., Medi\u0107-\u0160ari\u0107 M., Tomi\u010di\u0107 M. Interference of selected flavonoid aglycons in platelet aggregation assays. Clin. Chem. Lab. Med. 2012;50:1403\u20131408. doi: 10.1515/cclm-2011-0960.", "ArticleIdList": ["10.1515/cclm-2011-0960", "22868805"]}, {"Citation": "Fri\u0161\u010di\u0107 M., \u0160tibri\u0107 Baglama M., Milovi\u0107 M., Hazler Pilepi\u0107 K., Male\u0161 \u017d. Content of bioactive constituents and antioxidant potential of Galium L. species. Croat. Chem. Acta. 2018;91:1\u20137. doi: 10.5562/cca3379.", "ArticleIdList": ["10.5562/cca3379"]}, {"Citation": "Kale A., Gawande S., Kotwal S. Cancer phytotherapeutics: Role for flavonoids at the cellular level. Phytother. Res. 2008;22:567\u2013577. doi: 10.1002/ptr.2283.", "ArticleIdList": ["10.1002/ptr.2283", "18398903"]}, {"Citation": "Walle T., Ta N., Kawamori T., Wen X., Tsuji P.A., Walle U.K. Cancer chemopreventive properties of orally bioavailable flavonoids--methylated versus unmethylated flavones. Biochem. Pharmacol. 2007;73:1288\u20131296. doi: 10.1016/j.bcp.2006.12.028.", "ArticleIdList": ["10.1016/j.bcp.2006.12.028", "PMC1868573", "17250812"]}, {"Citation": "Zhang S., Yang X., Coburn R.A., Morris M.E. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem. Pharmacol. 2005;70:627\u2013639. doi: 10.1016/j.bcp.2005.05.017.", "ArticleIdList": ["10.1016/j.bcp.2005.05.017", "15979586"]}, {"Citation": "Martens S., Mith\u00f6fer A. Flavones and flavone synthases. Phytochemistry. 2005;66:2399\u20132407. doi: 10.1016/j.phytochem.2005.07.013.", "ArticleIdList": ["10.1016/j.phytochem.2005.07.013", "16137727"]}, {"Citation": "Csepanyi E., Szabados-Furjesi P., Kiss-Szikszai A., Frensemeier L.M., Karst U., Lekli I., Haines D.D., Tosaki A., Bak I. Antioxidant Properties and oxidative transformation of different chromone derivatives. Molecules. 2017;22:588. doi: 10.3390/molecules22040588.", "ArticleIdList": ["10.3390/molecules22040588", "PMC6153751", "28383511"]}, {"Citation": "Ami\u0107 D., Davidovi\u0107-Ami\u0107 D., Beslo D., Rastija V., Luci\u0107 B., Trinajsti\u0107 N. SAR and QSAR of the antioxidant activity of flavonoids. Curr. Med. Chem. 2007;14:827\u2013845. doi: 10.2174/092986707780090954.", "ArticleIdList": ["10.2174/092986707780090954", "17346166"]}, {"Citation": "Bubols G.B., Vianna Dda R., Medina-Remon A., von Poser G., Lamuela-Raventos R.M., Eifler-Lima V.L., Garcia S.C. The antioxidant activity of coumarins and flavonoids. Mini Rev. Med. Chem. 2013;13:318\u2013334.", "ArticleIdList": ["22876957"]}, {"Citation": "Chen L., Teng H., Xie Z., Cao H., Cheang W.S., Skalicka-Woniak K., Georgiev M.I., Xiao J. Modifications of dietary flavonoids towards improved bioactivity: An update on structure-activity relationship. Crit. Rev. Food Sci. Nutr. 2018;58:513\u2013527. doi: 10.1080/10408398.2016.1196334.", "ArticleIdList": ["10.1080/10408398.2016.1196334", "27438892"]}, {"Citation": "Machado N.F.L., Marques M.P.M. Bioactive Chromone Derivatives \u2013 Structural Diversity. Bioact. Compd. 2010;6:76\u201389. doi: 10.2174/157340710791184859.", "ArticleIdList": ["10.2174/157340710791184859"]}, {"Citation": "He W., Wu J.J., Ning J., Hou J., Xin H., He Y., Ge G.B., Xu W. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice. Toxicol. In Vitro. 2015;29:1569\u20131576. doi: 10.1016/j.tiv.2015.06.014.", "ArticleIdList": ["10.1016/j.tiv.2015.06.014", "26100226"]}, {"Citation": "Henderson M., Miranda C., Stevens J., Deinzer M., Buhler D. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica. 2000;30:235\u2013251. doi: 10.1080/004982500237631.", "ArticleIdList": ["10.1080/004982500237631", "10752639"]}, {"Citation": "Obach R.S. Inhibition of human cytochrome P450 enzymes by constituents of St. John\u2019s Wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther. 2000;294:88\u201395.", "ArticleIdList": ["10871299"]}, {"Citation": "Yuan Y., Qiu X., Nikolic D., Chen S.N., Huang K., Li G., Pauli G.F., van Breemen R.B. Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols. Eur. J. Pharm. Sci. 2014;53:55\u201361. doi: 10.1016/j.ejps.2013.12.003.", "ArticleIdList": ["10.1016/j.ejps.2013.12.003", "PMC3987852", "24342125"]}, {"Citation": "Zhai S., Dai R., Friedman F.K., Vestal R.E. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab. Dispos. 1998;26:989\u2013992.", "ArticleIdList": ["9763404"]}, {"Citation": "Shimada T. Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity. Toxicol. Res. 2017;33:79\u201396. doi: 10.5487/TR.2017.33.2.079.", "ArticleIdList": ["10.5487/TR.2017.33.2.079", "PMC5402866", "28443179"]}, {"Citation": "Hasler J.A., Estabrook R., Murray M., Pikuleva I., Waterman M., Capdevila J., Holla V., Helvig C., Falck J.R., Farrell G. Human cytochromes P450. Mol. Aspects Med. 1999;20:1\u2013137. doi: 10.1016/S0098-2997(99)00005-9.", "ArticleIdList": ["10.1016/S0098-2997(99)00005-9"]}, {"Citation": "Spaggiari D., Geiser L., Daali Y., Rudaz S. Phenotyping of CYP450 in human liver microsomes using the cocktail approach. Anal. Bioanal. Chem. 2014;406:4875\u20134887. doi: 10.1007/s00216-014-7915-4.", "ArticleIdList": ["10.1007/s00216-014-7915-4", "24894520"]}, {"Citation": "Guengerich F.P., Martin M.V., Beaune P.H., Kremers P., Wolff T., Waxman D.J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 1986;261:5051\u20135060.", "ArticleIdList": ["3514607"]}, {"Citation": "Satoh T., Fujisawa H., Nakamura A., Takahashi N., Watanabe K. Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities. J. Pharm. Pharm. Sci. 2016;19:188\u2013197. doi: 10.18433/J3MS5C.", "ArticleIdList": ["10.18433/J3MS5C", "27518169"]}, {"Citation": "Zanger U.M., Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 2013;138:103\u2013141. doi: 10.1016/j.pharmthera.2012.12.007.", "ArticleIdList": ["10.1016/j.pharmthera.2012.12.007", "23333322"]}, {"Citation": "Nguyen S., Huang H., Foster B.C., Tam T.W., Xing T., Smith M.L., Arnason J.T., Akhtar H. Antimicrobial and P450 inhibitory properties of common functional foods. J. Pharm. Pharm. Sci. 2014;17:254\u2013265. doi: 10.18433/J3P599.", "ArticleIdList": ["10.18433/J3P599", "24934554"]}, {"Citation": "Liu R., Tam T.W., Mao J., Saleem A., Krantis A., Arnason J.T., Foster B.C. The effect of natural health products and traditional medicines on the activity of human hepatic microsomal-mediated metabolism of oseltamivir. J. Pharm. Pharm. Sci. 2010;13:43\u201355. doi: 10.18433/J3ZP42.", "ArticleIdList": ["10.18433/J3ZP42", "20456830"]}, {"Citation": "Tam T.W., Akhtar H., Arnason J.T., Cvijovic K., Boon H., Cameron D.W., Drouin C.E., Jaeger W., Tsuyuki R.T., Vohra S., et al. Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins. J. Pharm. Pharm. Sci. 2011;14:1\u201316. doi: 10.18433/J3N30W.", "ArticleIdList": ["10.18433/J3N30W", "21501549"]}, {"Citation": "Tam T.W., Liu R., Saleem A., Arnason J.T., Krantis A., Foster B.C. Cytochrome P450 3A4 and 2D6-mediated metabolism of leisure and medicinal teas. J. Pharm. Pharm. Sci. 2014;17:294\u2013301. doi: 10.18433/J3902H.", "ArticleIdList": ["10.18433/J3902H", "25224344"]}, {"Citation": "De Lima Toccafondo Vieira M., Huang S.M. Botanical-drug interactions: A scientific perspective. Planta Med. 2012;78:1400\u20131415. doi: 10.1055/s-0032-1315145.", "ArticleIdList": ["10.1055/s-0032-1315145", "22864989"]}, {"Citation": "Hermann R., von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med. 2012;78:1458\u20131477. doi: 10.1055/s-0032-1315117.", "ArticleIdList": ["10.1055/s-0032-1315117", "22855269"]}, {"Citation": "\u010covi\u0107 D., Boji\u0107 M., Medi\u0107-\u0160ari\u0107 M. Metabolism of flavonoids and phenolic acids. Farm. Glas. 2009;65:693\u2013704."}, {"Citation": "Wu W.Y., Li Y.D., Cui Y.K., Wu C., Hong Y.X., Li G., Wu Y., Jie L.J., Wang Y., Li G.R. The natural flavone acacetin confers cardiomyocyte protection against hypoxia/reoxygenation injury via AMPK-mediated activation of Nrf2 signaling pathway. Front. Pharmacol. 2018;15:497. doi: 10.3389/fphar.2018.00497.", "ArticleIdList": ["10.3389/fphar.2018.00497", "PMC5962741", "29867499"]}, {"Citation": "Zhang H.W., Hu J.J., Fu R.Q., Liu X., Zhang Y.H., Li J., Liu L., Li Y.N., Deng Q., Luo Q.S., et al. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3K\u03b3 mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells. Sci. Rep. 2018;26:11255. doi: 10.1038/s41598-018-29308-7.", "ArticleIdList": ["10.1038/s41598-018-29308-7", "PMC6062549", "30050147"]}, {"Citation": "Gomez-Chang E., Uribe-Estanislao G.V., Martinez-Martinez M., G\u00e1lvez-Mariscal A., Romero I. Anti-Helicobacter pylori Potential of Three Edible Plants Known as Quelites in Mexico. J. Med. Food. 2018 doi: 10.1089/jmf.2017.0137.", "ArticleIdList": ["10.1089/jmf.2017.0137", "30036109"]}, {"Citation": "Doostdar H., Burke M.D., Mayer R.T. Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology. 2000;144:31\u201338. doi: 10.1016/S0300-483X(99)00215-2.", "ArticleIdList": ["10.1016/S0300-483X(99)00215-2", "10781868"]}, {"Citation": "Tao J., Shen C., Sun Y., Chen W., Yan G. Neuroprotective effects of pinocembrin on ischemia/reperfusion-induced brain injury by inhibiting autophagy. Biomed. Pharmacother. 2018;106:1003\u20131010. doi: 10.1016/j.biopha.2018.07.026.", "ArticleIdList": ["10.1016/j.biopha.2018.07.026", "30119165"]}, {"Citation": "Su Q., Sun Y., Ye Z., Yang H., Kong B., Li L. Pinocembrin protects endothelial cells from oxidized LDL-induced injury. Cytokine. 2018 doi: 10.1016/j.cyto.2018.05.033.", "ArticleIdList": ["10.1016/j.cyto.2018.05.033", "29914794"]}, {"Citation": "Cao G., Ying P., Yan B., Xue W., Li K., Shi A., Sun T., Yan J., Hu X. Pharmacokinetics, safety, and tolerability of single and multiple-doses of pinocembrin injection administered intravenously in healthy subjects. J. Ethnopharmacol. 2015;168:31\u201336. doi: 10.1016/j.jep.2015.03.041.", "ArticleIdList": ["10.1016/j.jep.2015.03.041", "25814318"]}, {"Citation": "Makanjuola S.B.L., Ogundaini A.O., Ajonuma L.C., Dosunmu A. Apigenin and apigeninidin isolates from the Sorghum bicolor leaf targets inflammation via cyclo-oxygenase-2 and prostaglandin-E2 blockade. Int. J. Rheum. Dis. 2018;21:1487\u20131495. doi: 10.1111/1756-185X.13355.", "ArticleIdList": ["10.1111/1756-185X.13355", "30146750"]}, {"Citation": "Lee J.A., Ha S.K., Cho E., Choi I. Resveratrol as a Bioenhancer to Improve Anti-Inflammatory Activities of Apigenin. Nutrients. 2015;7:9650\u20139661. doi: 10.3390/nu7115485.", "ArticleIdList": ["10.3390/nu7115485", "PMC4663613", "26610561"]}, {"Citation": "Nabavi S.M., Habtemariam S., Daglia M., Nabavi S.F. Apigenin and Breast Cancers: From Chemistry to Medicine. Anticancer Agents Med. Chem. 2015;15:728\u2013735. doi: 10.2174/1871520615666150304120643.", "ArticleIdList": ["10.2174/1871520615666150304120643", "25738871"]}, {"Citation": "Mrazek A.A., Porro L.J., Bhatia V., Falzon M., Spratt H., Zhou J., Chao C., Hellmich M.R. Apigenin inhibits pancreatic stellate cell activity in pancreatitis. J. Surg. Res. 2015;196:8\u201316. doi: 10.1016/j.jss.2015.02.032.", "ArticleIdList": ["10.1016/j.jss.2015.02.032", "PMC4430404", "25799526"]}, {"Citation": "Thangaiyan R., Robert B.M., Arjunan S., Govindasamy K., Nagarajan R.P. Preventive effect of apigenin against isoproterenol-induced apoptosis in cardiomyoblasts. J. Biochem. Mol. Toxicol. 2018:e22213. doi: 10.1002/jbt.22213.", "ArticleIdList": ["10.1002/jbt.22213", "30152906"]}, {"Citation": "Li Y., Ning J., Wang Y., Wang C., Sun C., Huo X., Yu Z., Feng L., Zhang B., Tian X., et al. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicol. Lett. 2018;294:27\u201336. doi: 10.1016/j.toxlet.2018.05.008.", "ArticleIdList": ["10.1016/j.toxlet.2018.05.008", "29753067"]}, {"Citation": "Kimura Y., Ito H., Ohnishi R., Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol. 2010;48:429\u2013435. doi: 10.1016/j.fct.2009.10.041.", "ArticleIdList": ["10.1016/j.fct.2009.10.041", "19883715"]}, {"Citation": "Tasdemir D., Kaiser M., Brun R., Yardley V., Schmidt T.J., Tosun F., R\u00fcedi P. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob. Agents Chemother. 2006;50:1352\u20131364. doi: 10.1128/AAC.50.4.1352-1364.2006.", "ArticleIdList": ["10.1128/AAC.50.4.1352-1364.2006", "PMC1426963", "16569852"]}, {"Citation": "Kang M.K., Park S.H., Choi Y.J., Shin D., Kang Y.H. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J. Mol. Med. (Berl.) 2015;93:759\u2013772. doi: 10.1007/s00109-015-1301-3.", "ArticleIdList": ["10.1007/s00109-015-1301-3", "26062793"]}, {"Citation": "Lin S., Zhang G., Liao Y., Pan J. Inhibition of chrysin on xanthine oxidase activity and its inhibition mechanism. Int. J. Biol. Macromol. 2015;81:274\u2013282. doi: 10.1016/j.ijbiomac.2015.08.017.", "ArticleIdList": ["10.1016/j.ijbiomac.2015.08.017", "26275460"]}, {"Citation": "Wang S., Zhang X., Liu M., Luan H., Ji Y., Guo P., Wu C. Chrysin inhibits foam cell formation through promoting cholesterol efflux from RAW264.7 macrophages. Pharm. Biol. 2015;53:1481\u20131487. doi: 10.3109/13880209.2014.986688.", "ArticleIdList": ["10.3109/13880209.2014.986688", "25857322"]}, {"Citation": "Quintieri L., Palatini P., Nassi A., Ruzza P., Floreani M. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. Biochem. Pharmacol. 2008;75:1426\u20131437. doi: 10.1016/j.bcp.2007.11.012.", "ArticleIdList": ["10.1016/j.bcp.2007.11.012", "18191104"]}, {"Citation": "Xu J.J., Liu Z., Tang W., Wang G.C., Chung H.Y., Liu Q.Y., Zhuang L., Li M.M., Li Y.L. Tangeretin from Citrus reticulate Inhibits Respiratory Syncytial Virus Replication and Associated Inflammation in Vivo. J. Agric. Food Chem. 2015;63:9520\u20139527. doi: 10.1021/acs.jafc.5b03482.", "ArticleIdList": ["10.1021/acs.jafc.5b03482", "26468759"]}, {"Citation": "Periyasamy K., Baskaran K., Ilakkia A., Vanitha K., Selvaraj S., Sakthisekaran D. Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats. Cancer Chemother. Pharmacol. 2015;75:263\u2013272. doi: 10.1007/s00280-014-2629-z.", "ArticleIdList": ["10.1007/s00280-014-2629-z", "25431347"]}, {"Citation": "Lakshmi A., Subramanian S.P. Tangeretin ameliorates oxidative stress in the renal tissues of rats with experimental breast cancer induced by 7,12-dimethylbenz[a]anthracene. Toxicol. Lett. 2014;229:333\u2013348. doi: 10.1016/j.toxlet.2014.06.845.", "ArticleIdList": ["10.1016/j.toxlet.2014.06.845", "24995432"]}, {"Citation": "Obermeier M.T., White R.E., Yang C.S. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica. 1995;25:575\u2013584. doi: 10.3109/00498259509061876.", "ArticleIdList": ["10.3109/00498259509061876", "7483658"]}, {"Citation": "Takanaga H., Ohnishi A., Yamada S., Matsuo H., Morimoto S., Shoyama Y., Ohtani H., Sawada Y. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J. Pharmacol. Exp. Ther. 2000;293:230\u2013236.", "ArticleIdList": ["10734174"]}, {"Citation": "Boji\u0107 M. Preclinical cytochrome P450 inhibition and interaction studies of new drug candidates. Farm. Glas. 2015;71:229\u2013242."}, {"Citation": "Zhang B.Y., Wang Y.M., Gong H., Zhao H., Lv X.Y., Yuan G.H., Han S.R. Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC) Int. J. Clin. Exp. Pathol. 2015;8:25\u201337.", "ArticleIdList": ["PMC4348816", "25755690"]}, {"Citation": "AbdalDayem A., Choi H.Y., Kim Y.B., Cho S.G. Antiviral effect of methylated flavonol isorhamnetin against influenza. PLoS ONE. 2015;10:e0121610.", "ArticleIdList": ["PMC4373826", "25806943"]}, {"Citation": "Wang X., Zhong W. Isorhamnetin attenuates collagen-induced arthritis via modulating cytokines and oxidative stress in mice. Int. J. Clin. Exp. Med. 2015;8:16536\u201316542.", "ArticleIdList": ["PMC4659069", "26629181"]}, {"Citation": "Ding L.L., Zhang J.J., Dou W. Effects of isorhamnetin on CYP3A4 and herb-drug interaction. Yao Xue Xue Bao. 2012;47:1006\u20131010.", "ArticleIdList": ["23162896"]}, {"Citation": "Ekstrand B., Rasmussen M.K., Woll F., Zlabek V., Zamaratskaia G. In vitro gender-dependent inhibition of porcine cytochrome p450 activity by selected flavonoids and phenolic acids. Biomed. Res. Int. 2015;2015:387918. doi: 10.1155/2015/387918.", "ArticleIdList": ["10.1155/2015/387918", "PMC4317639", "25685784"]}, {"Citation": "Park H.J., Lee S.J., Cho J., Gharbi A., Han H.D., Kang T.H., Kim Y., Lee Y., Park W.S., Jung I.D., et al. Tamarixetin exhibits anti-inflammatory activity and prevents bacterial sepsis by increasing IL-10 production. J. Nat. Prod. 2018;81:1435\u20131443. doi: 10.1021/acs.jnatprod.8b00155.", "ArticleIdList": ["10.1021/acs.jnatprod.8b00155", "29851490"]}, {"Citation": "Nicolini F., Burmistrova O., Marrero M.T., Torres F., Hern\u00e1ndez C., Quintana J., Est\u00e9vez F. Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells. Mol. Carcinog. 2014;53:939\u2013950.", "ArticleIdList": ["23765509"]}, {"Citation": "Li L., Stanton J.D., Tolson A.H., Luo Y., Wang H. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm. Res. 2009;26:872\u2013882. doi: 10.1007/s11095-008-9788-8.", "ArticleIdList": ["10.1007/s11095-008-9788-8", "PMC2649697", "19034627"]}, {"Citation": "Von Moltke L.L., Weemhoff J.L., Bedir E., Khan I.A., Harmatz J.S., Goldman P., Greenblatt D.J. Inhibition of human cytochromes P450 by components of Ginkgo biloba. J. Pharm. Pharmacol. 2004;56:1039\u20131044. doi: 10.1211/0022357044021.", "ArticleIdList": ["10.1211/0022357044021", "15285849"]}, {"Citation": "Van Waterschoot R.A., Rooswinkel R.W., Sparidans R.W., van Herwaarden A.E., Beijnen J.H., Schinkel A.H. Inhibition and stimulation of intestinal and hepatic CYP3A activity: Studies in humanized CYP3A4 transgenic mice using triazolam. Drug Metab. Dispos. 2009;37:2305\u20132313. doi: 10.1124/dmd.109.029397.", "ArticleIdList": ["10.1124/dmd.109.029397", "19752211"]}, {"Citation": "Boji\u0107 M., Barbero L., Dolgos H., Freisleben A., Gallemann D., Riva S., Guengerich F.P. Time- and NADPH-dependent inhibition of cytochrome P450 3A4 by the cyclopentapeptide cilengitide: Significance of the guanidine group and accompanying spectral changes. Drug Metab. Dispos. 2014;42:1438\u20131446. doi: 10.1124/dmd.114.059295.", "ArticleIdList": ["10.1124/dmd.114.059295", "24985702"]}]}], "History": [{"Year": "2018", "Month": "9", "Day": "7"}, {"Year": "2018", "Month": "9", "Day": "29"}, {"Year": "2018", "Month": "10", "Day": "5"}, {"Year": "2018", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["30301254", "PMC6222669", "10.3390/molecules23102553", "molecules23102553"]}}]}